Načítá se...

Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia

This study was conducted to investigate the outcomes of patients with chronic myeloid leukemia (CML) who discontinued tyrosine kinase inhibitor (TKI) treatment. A single-center retrospective analysis was performed, including 46 chronic-phase (CP) CML patients who achieved complete molecular response...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: TSUTSUMI, YUTAKA, ITO, SHINICHI, OHIGASHI, HIROYUKI, SHIRATORI, SOUICHI, TESHIMA, TAKANORI
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727029/
https://ncbi.nlm.nih.gov/pubmed/26870364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.653
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!